US5081032AExpiredUtility
Anti-human pulmonary adenocarcinoma monoclonal antibody
Est. expiryJun 30, 2008(expired)· nominal 20-yr term from priority
C07K 16/3023
38
PatentIndex Score
3
Cited by
14
References
2
Claims
Abstract
Anti-human pulmonary adenocarcinoma monoclonal antibody ALC-864 which belongs to the class IgG 1 , reacts with human pulmonary adenocarcinoma cells but not with normal human cells, recognizes proteins as antigens, and is useful for the identification of pulmonary adenocarcinoma selectively from among normal cells and for distinguishing this cancer from among other types of cancer.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. An anti-human pulmonary adenocarcinoma monoclonal antibody ALC-864 secreted by a hybridoma having all of the identifying characteristics of hybridoma cell line ALC-864, accession no. FERM BP-1783, which belongs to the class IgG 1 , and specifically binds to a protein antigen on human pulmonary adenocarcinoma cells but not to CEA or normal human lung cells as determined by enzyme-linked immunosorbent assay.
2. A hydridoma cell line having all of the identifying characteristics of hybridoma cell line ALC-864, deposited at the Fermentation Research Institute under the accession no. FERM BP-864.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.